183 related articles for article (PubMed ID: 35362546)
1. Tumor microenvironment manipulates chemoresistance in ovarian cancer (Review).
Zhang Q; Ding J; Wang Y; He L; Xue F
Oncol Rep; 2022 May; 47(5):. PubMed ID: 35362546
[TBL] [Abstract][Full Text] [Related]
2. Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer.
Kanlikilicer P; Bayraktar R; Denizli M; Rashed MH; Ivan C; Aslan B; Mitra R; Karagoz K; Bayraktar E; Zhang X; Rodriguez-Aguayo C; El-Arabey AA; Kahraman N; Baydogan S; Ozkayar O; Gatza ML; Ozpolat B; Calin GA; Sood AK; Lopez-Berestein G
EBioMedicine; 2018 Dec; 38():100-112. PubMed ID: 30487062
[TBL] [Abstract][Full Text] [Related]
3. Secreted Soluble Factors from Tumor-Activated Mesenchymal Stromal Cells Confer Platinum Chemoresistance to Ovarian Cancer Cells.
Koren Carmi Y; Khamaisi H; Adawi R; Noyman E; Gopas J; Mahajna J
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175439
[TBL] [Abstract][Full Text] [Related]
4. The Emerging Roles and Therapeutic Implications of Epigenetic Modifications in Ovarian Cancer.
Wang Y; Huang Z; Li B; Liu L; Huang C
Front Endocrinol (Lausanne); 2022; 13():863541. PubMed ID: 35620395
[TBL] [Abstract][Full Text] [Related]
5. Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion.
Tian W; Lei N; Zhou J; Chen M; Guo R; Qin B; Li Y; Chang L
Cell Death Dis; 2022 Jan; 13(1):64. PubMed ID: 35042862
[TBL] [Abstract][Full Text] [Related]
6. Revisiting macrophages in ovarian cancer microenvironment: development, function and interaction.
El-Arabey AA; Alkhalil SS; Al-Shouli ST; Awadalla ME; Alhamdi HW; Almanaa TN; Mohamed SSEM; Abdalla M
Med Oncol; 2023 Apr; 40(5):142. PubMed ID: 37039909
[TBL] [Abstract][Full Text] [Related]
7. Role of Cancer-Associated fibroblast in the pathogenesis of ovarian Cancer: Focus on the latest therapeutic approaches.
Ding H; Zhang J; Zhang F; Xu Y; Yu Y; Liang W; Li Q
Int Immunopharmacol; 2022 Sep; 110():109052. PubMed ID: 35978506
[TBL] [Abstract][Full Text] [Related]
8. Extracellular Vesicles in Chemoresistance.
De Rubis G; Bebawy M
Subcell Biochem; 2021; 97():211-245. PubMed ID: 33779919
[TBL] [Abstract][Full Text] [Related]
9. Flavonoids Restore Platinum Drug Sensitivity to Ovarian Carcinoma Cells in a Phospho-ERK1/2-Dependent Fashion.
Koren Carmi Y; Mahmoud H; Khamaisi H; Adawi R; Gopas J; Mahajna J
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32906729
[TBL] [Abstract][Full Text] [Related]
10. The Role of Tumor-Associated Macrophages in the Progression and Chemoresistance of Ovarian Cancer.
Nowak M; Klink M
Cells; 2020 May; 9(5):. PubMed ID: 32456078
[TBL] [Abstract][Full Text] [Related]
11. Mimicking the tumor microenvironment: Fibroblasts reduce miR-29b expression and increase the motility of ovarian cancer cells in a co-culture model.
Medeiros M; Ribeiro AO; Lupi LA; Romualdo GR; Pinhal D; Chuffa LGA; Delella FK
Biochem Biophys Res Commun; 2019 Aug; 516(1):96-101. PubMed ID: 31200958
[TBL] [Abstract][Full Text] [Related]
12. The potential role of exosomes derived from ovarian cancer cells for diagnostic and therapeutic approaches.
Yang C; Kim HS; Song G; Lim W
J Cell Physiol; 2019 Dec; 234(12):21493-21503. PubMed ID: 31144314
[TBL] [Abstract][Full Text] [Related]
13. Adipose-derived stem cells in ovarian cancer progression, metastasis, and chemoresistance.
Zhang W; Torres-Rojas C; Yue J; Zhu BM
Exp Biol Med (Maywood); 2021 Aug; 246(16):1810-1815. PubMed ID: 34229470
[TBL] [Abstract][Full Text] [Related]
14. Ovarian cancer microenvironment: implications for cancer dissemination and chemoresistance acquisition.
Thibault B; Castells M; Delord JP; Couderc B
Cancer Metastasis Rev; 2014 Mar; 33(1):17-39. PubMed ID: 24357056
[TBL] [Abstract][Full Text] [Related]
15. LncRNA MALAT1 Facilitates Ovarian Cancer Progression through Promoting Chemoresistance and Invasiveness in the Tumor Microenvironment.
Mao TL; Fan MH; Dlamini N; Liu CL
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638541
[TBL] [Abstract][Full Text] [Related]
16. Tumor microenvironment promotes breast cancer chemoresistance.
Mehraj U; Dar AH; Wani NA; Mir MA
Cancer Chemother Pharmacol; 2021 Feb; 87(2):147-158. PubMed ID: 33420940
[TBL] [Abstract][Full Text] [Related]
17. Cross‑validation of genes potentially associated with neoadjuvant chemotherapy and platinum‑based chemoresistance in epithelial ovarian carcinoma.
Zhang K; Wang W; Chen L; Liu Y; Hu J; Guo F; Tian W; Wang Y; Xue F
Oncol Rep; 2020 Sep; 44(3):909-926. PubMed ID: 32705213
[TBL] [Abstract][Full Text] [Related]
18. The role of ABC transporters in ovarian cancer progression and chemoresistance.
Ween MP; Armstrong MA; Oehler MK; Ricciardelli C
Crit Rev Oncol Hematol; 2015 Nov; 96(2):220-56. PubMed ID: 26100653
[TBL] [Abstract][Full Text] [Related]
19. Tumor-Derived Extracellular Vesicles Promote Activation of Carcinoma-Associated Fibroblasts and Facilitate Invasion and Metastasis of Ovarian Cancer by Carrying miR-630.
Cui Y; Wang D; Xie M
Front Cell Dev Biol; 2021; 9():652322. PubMed ID: 34277601
[TBL] [Abstract][Full Text] [Related]
20. Overexpressed COL5A1 is correlated with tumor progression, paclitaxel resistance, and tumor-infiltrating immune cells in ovarian cancer.
Zhang J; Zhang J; Wang F; Xu X; Li X; Guan W; Men T; Xu G
J Cell Physiol; 2021 Oct; 236(10):6907-6919. PubMed ID: 33655494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
